Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7229613 | DAIICHI SANKYO INC | Method for lowering serum glucose |
Apr, 2022
(9 months ago) |
Market Authorisation Date: 03 April, 2019
Treatment: A method for reducing serum glucose levels in adults with type 2 diabetes mellitus
Dosage: BAR, CHEWABLE;ORAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7229613 | DAIICHI SANKYO | Method for lowering serum glucose |
Apr, 2022
(9 months ago) | |
US7229613
(Pediatric) | DAIICHI SANKYO | Method for lowering serum glucose |
Oct, 2022
(3 months ago) |
Exclusivity | Exclusivity Expiration |
---|---|
M | Oct 20, 2024 |
Market Authorisation Date: 02 October, 2009
Treatment: Treatment of type 2 diabetes mellitus
Dosage: FOR SUSPENSION;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic